PLoS ONE · 2017 · 46 citations · 24 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntifungal PharmacologyAntifungal ResistanceBiofilm FormationBiofilm Formation In InfectionFungal PathogenesisFungal PhysiologyBiofilm DevelopmentBiofilm Formation GenesBiofilm Gene RegulationBiofilm InhibitionCandida Albicans InfectionCandida Biofilm PreventionCandida BiofilmsHyphal Development
The aim of this study was to investigate the ability of hinokitiol to inhibit the formation of Candida biofilms. Biofilm inhibition was evaluated by quantification of the biofilm metabolic activity with XTT assay. Hinokitiol efficiently prevented biofilm formation in both fluconazole-susceptible and fluconazole-resistant strains of Candida species. We determined the expression levels of specific genes previously implicated in biofilm development of C. albicans cells by real-time RT-PCR. The expression levels of genes associated with adhesion process, HWP1 and ALS3, were downregulated by hinokitiol. Transcript levels of UME6 and HGC1, responsible for long-term hyphal maintenance, were also decreased by hinokitiol. The expression level of CYR1, which encodes the component of signaling pathway of hyphal formation-cAMP-PKA was suppressed by hinokitiol. Its upstream general regulator RAS1 was also suppressed by hinokitiol. These results indicate that hinokitiol may have therapeutic potential in the treatment and prevention of biofilm-associated Candida infections.
24
Evolution of pathogenicity and sexual reproduction in eight Candida genomes
Geraldine Butler, Matthew D. Rasmussen, Michael Lin et al. · Nature · 2009 · 1.1K citations · Full text